Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Beyond Meat reported that it failed to meet market expectations during its quarterly revenue report, as the company has faced weakening demand for its plant-based meat products.
Finding a new job is an emotional journey in itself and one woman is looking to get back into the workforce after some time off. Cheddar News' docuseries Ready 4 Work profiles her as she works through her job search.
Virgin Galactic has announced plans to pause flight operations next year so they can focus more on developing its next-generation delta class spacecraft.
